Zoetis | ZTS - Cost Of Sales

Stock Price
80.07
Daily Change
0.36 0.45%
Monthly
-31.87%
Yearly
-50.56%
Q2 Forecast
72.73

Zoetis reported $672M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
AbbVie USD 4.22B 329M Mar/2026
Align Technology USD 303.5M 60.47M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Coherus Biosciences USD 4.04M 324K Dec/2025
Dentsply International USD 453M 65M Mar/2026
Eli Lilly USD 3.58B 205M Mar/2026
Henry Schein USD 2.3B 145M Mar/2026
Idexx Laboratories USD 418.08M 14.38M Mar/2026
Illumina USD 370M 30M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
J&J USD 8.07B 103M Mar/2026
Laboratory Of America USD 2.6B 4.2M Mar/2026
Merck USD 2.94B 380M Mar/2026
Neogen USD 112.2M 5.81M Dec/2025
Pacira USD 50.74M 3.89M Mar/2026
Perrigo USD 643.7M 103.7M Mar/2026
Pfizer USD 4.59B 1.7B Mar/2026
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Quest Diagnostics USD 1.99B 57M Mar/2026
Sanofi EUR 3.67B 621M Mar/2026
Sanofi EUR 3.76B 344M Dec/2025
Zoetis USD 672M 71M Mar/2026